A groundbreaking development in the fight against multiple sclerosis (MS) has emerged from Australia, offering a glimmer of hope to those affected by this debilitating disease. The power of genetics is about to unlock a new era of understanding and treatment.
Led by Dr. Hamish King at WEHI, this ambitious project aims to unravel the complex web of over 100 genetic risk factors associated with MS. By studying these factors collectively, researchers are taking a giant leap towards comprehending the disease's development and, ultimately, improving the lives of MS patients.
But here's where it gets controversial: most of these genetic changes don't directly alter genes. Instead, they influence the on-off switch of genes within immune cells, creating a challenging puzzle for scientists to decipher. Dr. King's team is now tackling this head-on, introducing and testing these risk factors in human immune cells to measure their impact on gene activity and immune behavior.
Dr. King emphasizes the potential for more precise treatments and better long-term outcomes for MS patients. "Understanding how these risk genes operate together is crucial," he says. "It's like piecing together a complex puzzle to reveal the full picture."
MS, an immune-mediated condition, occurs when the body attacks its own brain and spinal cord, damaging the protective myelin coating around nerve fibers. This can lead to mobility issues, vision problems, cognitive impairments, and energy loss.
In Australia alone, the number of MS patients has risen to over 37,700 in 2025, a staggering 77.4% increase since 2010. The economic burden of the disease reached a staggering $3 billion in 2024.
As the MS community continues to grow, the urgency for accelerated research is palpable. MS Australia's Head of Research, Dr. Tennille Luker, highlights the critical gap between genetic discovery and real-world impact. "Identifying risk is just the first step. Understanding how these genetic changes drive the disease is key to changing its course."
Alongside Dr. King's project, MS Australia is investing in research to slow progression, manage symptoms, and improve quality of life. These efforts aim to strengthen the scientific foundation for prevention and potential cures.
The impact of sustained national investment in research cannot be overstated, as CEO Rohan Greenland emphasizes: "Research is hope. It gives people living with MS a reason to believe in progress and the possibility of better treatments and prevention."
The research grants, including a Postdoctoral Fellowship funded by the Browne Family, will be formally launched at Parliament House in Canberra on March 4th. This event, "Advancing MS Research in Australia," will highlight the importance of continued national commitment to MS research, with speakers like Dr. Monique Ryan MP and Ms. Renee Coffey MP.
Featured projects include:
- Sensory Shoe Insoles for Improved Balance in MS: Associate Professor Anna Hatton from The University of Queensland is developing insoles to enhance foot sensation and improve balance. The goal is to reduce fall risks and support mobility and independence for MS patients.
- Protecting Brain Blood Flow to Slow MS Progression: Professor Kaylene Young from the Menzies Institute for Medical Research is investigating how changes in brain blood vessels contribute to MS progression. The aim is to identify drug targets that protect myelin and slow disability.
- Investigating Viral Triggers of MS: Mr. Alex Eisner from The Florey Institute of Neuroscience and Mental Health is examining how common viruses like Epstein-Barr may influence MS by altering immune response and gene expression. The project aims to clarify the molecular mechanisms underlying viral infections and their impact on MS risk and treatment.
- Exploring Copper Disruption as a Key MS Risk Factor: Dr. Brittney Lins from Curtin University is investigating whether disrupted copper levels in the brain connect major MS risk factors like Epstein-Barr virus infection, vitamin D deficiency, and gut health. The project aims to identify new prevention and treatment strategies by understanding copper's role in myelin damage.
These projects represent a diverse range of approaches, each contributing to the broader goal of unraveling the complexities of MS and improving the lives of those affected. As research continues to advance, the hope is that these efforts will bring us closer to a world where MS is a manageable condition, and ultimately, a thing of the past.
